Institute

Back to overview
Name

Institut für Pharmazeutische Wissenschaften ETH Zürich

Address Institut für Pharmazeutische Wissenschaften ETH Zürich
Vladimir-Prelog-Weg 1-5/10
8093
CH-Zürich
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Synthesis and biological evaluation of novel, epothilone analogs and conjugates and prodrugs thereof
Altmann Karl-Heinz ETH Zurich - ETHZ 01.10.2005 30.09.2007 Project funding (Div. I-III)

Interactions of Leukocytes within and with Lymphatic Vessels: Elucidating their Impact on Immune Regulation and Leukocyte Migration
Halin Cornelia ETH Zurich - ETHZ 01.10.2018 30.09.2022 Project funding (Div. I-III)

Natural Products as Lead Structures for Anticancer and Antibacterial Drug Discovery: SAR Evaluation of Zampanolide and Pyridomycin
Altmann Karl-Heinz ETH Zurich - ETHZ 01.04.2014 31.03.2017 Project funding (Div. I-III)

Purificazione di peptidi di VGF coinvolti nel controlle dell'omeostasi energetica e in processi infiammatori
La Corte Giorgio ETH Zurich - ETHZ 01.03.2005 31.05.2005 International short research visits

Novel enzymatic methods for the site-specific modification of therapeutic proteins
Schibli Roger ETH Zurich - ETHZ 01.05.2008 30.04.2010 Project funding (Div. I-III)

Colloidal vesicles for drug detoxification
Leroux Jean-Christophe ETH Zurich - ETHZ 01.01.2010 31.12.2012 Project funding (Div. I-III)

Functional nanomedicines for improved anticancer chemotherapy
Leroux Jean-Christophe ETH Zurich - ETHZ 01.05.2012 30.04.2015 Project funding (Div. I-III)

Natural Products as Lead Structures for Anticancer and Antibacterial Drug Discovery: SAR Evaluation of Zampanolide and Pyridomycin
Altmann Karl-Heinz ETH Zurich - ETHZ 01.10.2017 31.03.2019 Project funding (Div. I-III)

Optimization of a small-molecule tracer for the imaging of human CD80 by Positron Emission Tomography (PET)
Krämer Stefanie Dorothea ETH Zurich - ETHZ 01.05.2018 30.04.2019 Project funding (Div. I-III)

3D printing manufacturing of patient-tailored drug releasing stents
Leroux Jean-Christophe ETH Zurich - ETHZ 01.09.2018 31.08.2022 Sinergia

Il progetto prevede l'isolamento di anticorpi monoclonali umanizzati diretti contro l'antigene FGFR1 utilizzando la libreria fagica anticorpale ETH2-Gold
Telaro Daniela ETH Zurich - ETHZ 01.08.2006 30.09.2006 International short research visits

Early Auto-processing of Bacterial Toxins as a Therapeutic Approach
Leroux Jean-Christophe ETH Zurich - ETHZ 01.07.2012 31.10.2014 Project funding (Div. I-III)

Identification of adhesion molecules involved in dendrtic cell migration into lymphatics
Halin Cornelia ETH Zurich - ETHZ 01.05.2007 31.07.2010 Project funding (Div. I-III)

Molecular mechanisms of angiogenesis and lymphangiogenesis in inflammation and cancer progression
Detmar Michael ETH Zurich - ETHZ 01.05.2010 30.04.2013 Project funding (Div. I-III)

Targeted polymers for site-specific drug delivery
Schibli Roger Paul Scherrer Institute - PSI 01.03.2010 29.02.2012 SCOPES

Computergestützer Entwurf und biophysikalische Charakterisierung immunmodulatorischer und antibakterieller Peptide und Peptidomimetika
Schneider Gisbert ETH Zurich - ETHZ 01.08.2011 31.07.2014 Project funding (Div. I-III)

Understanding and improving the selective molecular targeting of tumor neo-vasculature
Neri Dario ETH Zurich - ETHZ 01.10.2009 30.09.2012 Project funding (Div. I-III)

Biologically functionalized biodegradable nerve conduits for peripheral nerve regeneration
Gander Bruno ETH Zurich - ETHZ 01.01.2012 31.12.2014 Project funding (Div. I-III)

Metal-free 18F-Trifluoromethylation of Arenes in high molar activities
Gruber Stefan ETH Zurich - ETHZ 01.12.2019 31.01.2021 Spark

Understanding and improving the selective molecular targeting of neovasculature
Neri Dario ETH Zurich - ETHZ 01.10.2004 30.09.2009 Project funding (Div. I-III)

Elucidating the mechanism and the functional significance of leukocyte migration through afferent lymphatic vessels
Halin Cornelia ETH Zurich - ETHZ 01.01.2015 31.12.2017 Project funding (Div. I-III)

Ligands for the modulation of microRNA biogenesis and function
Hall Jonathan ETH Zurich - ETHZ 01.01.2013 31.12.2015 Project funding (Div. I-III)

Imaging immunogenic hot-spots in disease with PET by targeting the co-stimulatory molecule CD80 (B7-1)
Krämer Stefanie Dorothea ETH Zurich - ETHZ 01.03.2015 30.04.2018 Project funding (Div. I-III)

Natural Products as Lead Structures for Anticancer Drug Discovery: Synthesis and SAR of Rhizoxin Analogs
Altmann Karl-Heinz ETH Zurich - ETHZ 01.01.2010 31.12.2012 Project funding (Div. I-III)

Celiac disease - Improving enzymatic oral therapies via polymer conjugation
Leroux Jean-Christophe ETH Zurich - ETHZ 01.11.2011 31.03.2015 Project funding (Div. I-III)

Novel enzymatic methods for the site-specific modification of therapeutic proteins
Schibli Roger ETH Zurich - ETHZ 01.05.2006 30.04.2008 Project funding (Div. I-III)

Natural Products as Lead Structures for Anticancer Drug Discovery: Synthesis and SAR of Rhizoxin Analogs
Altmann Karl-Heinz ETH Zurich - ETHZ 01.01.2013 31.08.2013 Project funding (Div. I-III)

Understanding and exploiting the molecular targeting of tumor neo-vasculature
Neri Dario ETH Zurich - ETHZ 01.10.2012 30.09.2015 Project funding (Div. I-III)

The function of podoplanin in tumor progression and lymphangiogenesis
Detmar Michael ETH Zurich - ETHZ 01.05.2005 30.04.2010 Project funding (Div. I-III)

Molecular mechanisms underlying vertebrate kidney organogenesis
Brändli André ETH Zurich - ETHZ 01.12.2006 31.01.2009 Project funding (Div. I-III)

Total Synthesis and SAR Studies on Griseoviridin as a Potential Lead for New Antibiotic Drug Discovery
Altmann Karl-Heinz ETH Zurich - ETHZ 01.07.2019 31.10.2022 Project funding (Div. I-III)

Ligand-based design of new petidomimetics targeting the CGRP-receptor
Steuer Christian ETH Zurich - ETHZ 01.06.2019 31.08.2019 Scientific Exchanges

De novo molecular design by deep learning
Schneider Gisbert ETH Zurich - ETHZ 01.01.2019 31.12.2022 Project funding (Div. I-III)

Synthesis and Biological Evaluation of Novel Epothilone Analogs and Conjugates and Prodrugs thereof
Altmann Karl-Heinz ETH Zurich - ETHZ 01.10.2007 30.11.2009 Project funding (Div. I-III)

Elucidating the impact of inflammation on lymphatic vessel function and on the induction of adaptive immunity
Halin Cornelia ETH Zurich - ETHZ 01.11.2011 31.10.2014 Project funding (Div. I-III)

Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature
Neri Dario ETH Zurich - ETHZ 01.10.2015 30.09.2018 Project funding (Div. I-III)

The role of lymphatic vessels in cancer progression
Detmar Michael ETH Zurich - ETHZ 01.05.2016 30.04.2019 Project funding (Div. I-III)

Treating hyperammonemia with orally administered polymersomes
Leroux Jean-Christophe ETH Zurich - ETHZ 01.11.2016 31.10.2019 Project funding (Div. I-III)

Role of lymphatic vessels in cancer progression
Detmar Michael ETH Zurich - ETHZ 01.05.2019 31.01.2022 Project funding (Div. I-III)

Molecular mechanisms underlying kidney organogenesis and vascular development of Xenopus
Brändli André ETH Zurich - ETHZ 01.10.2003 30.09.2006 Project funding (Div. I-III)

Chemical Approaches to Functionalize Human microRNAs
Hall Jonathan ETH Zurich - ETHZ 01.10.2016 30.09.2019 Project funding (Div. I-III)

Beyond fragment-based drug design: from natural products to small synthetic mimetics through novel holistic molecular representations
Schneider Gisbert ETH Zurich - ETHZ 01.11.2017 31.01.2018 Scientific Exchanges

Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature
Neri Dario ETH Zurich - ETHZ 01.10.2018 31.12.2020 Project funding (Div. I-III)

Focused Ultrasound-Mediated Delivery of Encapsulated MGMT Antagonists for the Treatment of Temozolomide-Resistant Glioblastoma
Leroux Jean-Christophe ETH Zurich - ETHZ 01.03.2014 31.05.2017 Sinergia

Computational design of custom-tailored chemokine receptor blockers
Schneider Gisbert ETH Zurich - ETHZ 01.09.2015 31.08.2018 Interdisciplinary projects

Engineering the Targeted Drugs of the Future: A General Approach
Neri Dario ETH Zurich - ETHZ 01.08.2015 31.07.2018 Sinergia

Experiment-guided computational de novo exploration of peptide-membrane interaction
Schneider Gisbert ETH Zurich - ETHZ 01.01.2015 30.04.2018 Project funding (Div. I-III)

Chemical biology in microRNA pathways
Hall Jonathan ETH Zurich - ETHZ 01.01.2010 31.12.2012 Project funding (Div. I-III)

Chemical proteomics for the discovery of glioma stem cell markers
Pedretti Marta ETH Zurich - ETHZ 01.01.2008 30.04.2010 Marie Heim-Voegtlin grants

Function and Regulation of Cannabinoid Receptors in Primary Monocytes and Osteoclasts
Gertsch Jürg ETH Zurich - ETHZ 01.05.2008 30.04.2011 Project funding (Div. I-III)

Novel routes to 18F-labelled amino acids and vitamin derivatives useful for non-invasive, nuclear imaging of oncological and neurodegenerative diseases
Schibli Roger ETH Zurich - ETHZ 01.05.2014 30.04.2016 SCOPES

Systematic identification and characterization of RNA-binding proteins
Gerber André ETH Zurich - ETHZ 01.05.2006 30.04.2009 Project funding (Div. I-III)

Reversible and tunable PEGylation at arginine residues
Leroux Jean-Christophe ETH Zurich - ETHZ 01.09.2012 31.08.2015 Project funding (Div. I-III)

Molecular mechanisms of angiogenesis and lymphangiogenesis in inflammation and cancer progression
Detmar Michael ETH Zurich - ETHZ 01.05.2013 30.04.2016 Project funding (Div. I-III)

Engineering ‘smart’ viral RNA structures for stable and targeted siRNA delivery
Hill Alyssa ETH Zurich - ETHZ 01.01.2020 31.12.2020 Spark

Enhancing the Red Emission of Perylene Diimide in Solid or Aggregated State by Simple Polymerization
Bao Yinyin ETH Zurich - ETHZ 01.02.2020 30.04.2021 Spark
-